Parvovirus B19 Analysis
Use
This test provides analysis of parvovirus B19 in amniotic fluid. It is particularly indicated for prenatal ultrasound findings that suggest the presence of an infectious pathogen. Given the potential impact on maternal and fetal health, timely and accurate testing plays a crucial role in managing risks during pregnancy. Results should be interpreted alongside relevant clinical and ultrasound information for effective decision making.
Special Instructions
For optimal accuracy, the sample must be collected in a sterile, leak-proof container. Shipping of the specimen should also occur in a sterile, leak-proof container to prevent contamination. It is important for the healthcare provider to consider ultrasound findings and relevant clinical history when interpreting results from this analysis. Providers may refer to additional resources about avoiding infections during pregnancy for further patient guidance.
Limitations
While this test is very specific for detecting parvovirus B19 in amniotic fluid, false negatives can occur if the virus is not present at detectable levels in the collected sample. Additionally, interpretation of the test results should consider clinical symptoms and other relevant diagnostic information. It is essential to follow up with healthcare providers for comprehensive care and management strategies following test results.
Methodology
PCR-based (RT-PCR)
Biomarkers
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen
Amniotic Fluid (Unknown)
Volume
1 mL
Minimum Volume
1 mL
Container
sterile leak-proof container
Collection Instructions
Collect 1 mL amniotic fluid in a sterile leak-proof container
Causes for Rejection
contaminated samples
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | unspecified |
| Refrigerated | unspecified |
| Frozen | unspecified |